Literature DB >> 32723116

Treatment of severe pemphigus vulgaris during COVID-19 pandemic.

Yashdeep Singh Pathania1, Abhishek Bhardwaj1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32723116     DOI： 10.1080/09546634.2020.1801971

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN： 0954-6634            Impact factor:   3.359


× No keyword cloud information.
  2 in total

1.  Adverse outcome and severity of COVID-19 in patients with autoimmune bullous diseases: A historical cohort study.

Authors:  Fateme Shirzad Moghadam; Nika Kianfar; Shayan Dasdar; Rana Samii; Zeinab Farimani; Pedram Molhem Azar; Kamran Balighi; Robabeh Abedini; Tahereh Soori; Ali Salehi Farid; Hamidreza Mahmoudi; Maryam Daneshpazhooh
Journal:  Dermatol Ther       Date:  2022-07-21       Impact factor: 3.858

Review 2.  Pemphigus during the COVID-19 Epidemic: Infection Risk, Vaccine Responses and Management Strategies.

Authors:  Xueyi Huang; Xiaoqian Liang; Jiao Zhang; Hang Su; Yongfeng Chen
Journal:  J Clin Med       Date:  2022-07-08       Impact factor: 4.964
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.